High-dose tamoxifen in high-hormone-receptor-expressing advanced breast cancer patients: a phase II pilot study.

Yanhong SuYarui ZhangXin HuaJiajia HuangXiwen BiWen XiaXinyue WangZhangzan HuangChenge SongYongyi ZhongYanxia ShiShu-Sen Wangnull nullWei FanZhongyu Yuan

Published in: Therapeutic advances in medical oncology (2021)

[ClinicalTrials.gov identifier: NCT0304565].

Keyphrases

phase ii
high dose
clinical trial
open label
stem cell transplantation
low dose
phase iii
placebo controlled
double blind
breast cancer cells
estrogen receptor
positive breast cancer
study protocol